Pituitary & hypothalamus

Clinical Characteristics and Postoperative Growth in Japanese Children with Craniopharyngioma

Clin Endocrinol (Oxf)Published Retrospective cohort study

Authors' conclusion

Children with CP have distinctive clinical characteristics and postoperative growth patterns. Identifying symptoms using school-based auxological measurements could help in early diagnosis.

Study context

Population
Japanese children diagnosed with craniopharyngioma undergoing trans-sphenoidal or trans-cranial surgery, or both, followed up ≥3 years, Toranomon Hospital, Tokyo; median age at diagnosis 9.3 (0.9–18) years; 44 females
Participants
73 children
Outcome
Clinical characteristics and postoperative growth
Methodological detailssingle-centre, retrospective analysis of medical records (2000-2022)
  • Single-centre
  • Retrospective analysis of medical records (2000-2022)

Main finding

As reported in the abstract

Height SDS at diagnosis
−1.7 (−4.0 to 1.3)
Body mass index (BMI) SDS at diagnosis
0.21 (−2.3 to 2.2)
Chief complaint neurologic
n = 25, 34.2%
Chief complaint endocrine
n = 22, 30.1%
Chief complaint ophthalmic
n = 22, 30.1%
Accompanying neurologic symptoms
34 (46.6%)
Accompanying endocrine symptoms
63 (86.3%)
Accompanying ophthalmic symptoms
37 (50.7%)
Growth without GH (growth without growth hormone (GWGH)) 1 year after surgery
7 (13%)
GWGH transient (MRI-evident hypothalamic involvement category)
n = 3, 5.6%
GWGH permanent (MRI-evident hypothalamic involvement category)
n = 4, 7.4%
Preoperative hydrocephalus, the only factor significantly associated with postoperative GWGH at 1 year
n = 21, 32.8%; p = 0.037

Observational data: associations, not effects.

Original publication

Clinical Characteristics and Postoperative Growth in Japanese Children with Craniopharyngioma. Clin Endocrinol (Oxf). Published 28 February 2025. doi:10.1111/cen.15224

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.